Format
Sort by
Items per page

Send to

Choose Destination

Best matches for blood glucose AND hypoglycemia AND inpatient AND insulin:

Search results

Items: 1 to 20 of 290

1.

Glucose Management in Hospitalized Patients.

Kodner C, Anderson L, Pohlgeers K.

Am Fam Physician. 2017 Nov 15;96(10):648-654.

PMID:
29431385
2.

Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.

Uemura F, Okada Y, Torimoto K, Tanaka Y.

Diabetes Technol Ther. 2018 Feb;20(2):140-146. doi: 10.1089/dia.2017.0306. Epub 2018 Jan 2.

PMID:
29293363
3.

Update on Glucose Management Among Noncritically Ill Patients Hospitalized on Medical and Surgical Wards.

Gupta T, Hudson M.

J Endocr Soc. 2017 Feb 22;1(4):247-259. doi: 10.1210/js.2016-1055. eCollection 2017 Apr 1. Review.

4.

Decreased Rates of Inpatient Hypoglycemia Following Implementation of an Automated Tool in the Electronic Medical Record for Identifying Root Causes.

Sinha Gregory N, Seley JJ, Ukena J, Shah S, Fred MR, Dargar SK, Mauer E, Kim RJ.

J Diabetes Sci Technol. 2018 Jan;12(1):63-68. doi: 10.1177/1932296817744808. Epub 2017 Dec 17.

PMID:
29251063
5.

The Effect of Continuous Glucose Monitoring in Preventing Inpatient Hypoglycemia in General Wards: The Glucose Telemetry System.

Spanakis EK, Levitt DL, Siddiqui T, Singh LG, Pinault L, Sorkin J, Umpierrez GE, Fink JC.

J Diabetes Sci Technol. 2018 Jan;12(1):20-25. doi: 10.1177/1932296817748964. Epub 2017 Dec 13.

PMID:
29237288
6.

Treatment of mild-to-moderate hypoglycemia in patients with type 1 diabetes treated with insulin pump therapy: are current recommendations effective?

Gingras V, Desjardins K, Smaoui MR, Savard V, Messier V, Haidar A, Legault L, Rabasa-Lhoret R.

Acta Diabetol. 2017 Dec 9. doi: 10.1007/s00592-017-1085-8. [Epub ahead of print]

PMID:
29224132
7.

HIGH-DOSE GLUCOCORTICOID TREATMENT DOES NOT INDUCE SEVERE HYPERGLYCEMIA IN YOUNG PATIENTS WITH AUTOIMMUNE DISEASES BY CGMS.

Zhou Y, Zhao Y, Yuan T, Jiang N, Dong Y, Yang Y, Wang L, Zhao J, Min L, Zhao W.

Endocr Pract. 2018 Jan;24(1):60-68. doi: 10.4158/EP171820.OR. Epub 2017 Nov 6.

PMID:
29106815
8.

Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors.

Zhang T, Ji L, Gao Y, Zhang P, Zhu D, Li X, Ji J, Zhao F, Zhang H, Guo X.

Diabetes Technol Ther. 2017 Nov;19(11):675-684. doi: 10.1089/dia.2017.0111. Epub 2017 Nov 1.

PMID:
29090977
9.

Neutral protamine hagedorn/regular insulin in the treatment of inpatient hyperglycemia: Comparison of 3 basal-bolus regimens.

Quintanilla-Flores DL, González-González JG, García-De la Cruz G, Tamez-Pérez HE.

World J Diabetes. 2017 Oct 15;8(10):455-463. doi: 10.4239/wjd.v8.i10.455.

10.

The burden of severe hypoglycemia in type 2 diabetes.

Liu J, Wang R, Ganz ML, Paprocki Y, Schneider D, Weatherall J.

Curr Med Res Opin. 2018 Jan;34(1):179-186. doi: 10.1080/03007995.2017.1391080. Epub 2017 Nov 13.

PMID:
29017368
11.

Comparison of Insulin Detemir and Insulin Glargine for Hospitalized Patients on a Basal-Bolus Protocol.

Davis S, Friece C, Roderman N, Newcomer D, Castaneda E.

Pharmacy (Basel). 2017 Apr 23;5(2). pii: E22. doi: 10.3390/pharmacy5020022.

12.

Management of Type 1 Diabetes in the Hospital Setting.

Mendez CE, Umpierrez GE.

Curr Diab Rep. 2017 Sep 14;17(10):98. doi: 10.1007/s11892-017-0919-7. Review.

PMID:
28913745
13.

Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.

Harris C, Forst T, Heise T, Plum-Mörschel L, Watkins E, Zhang Q, Fan L, Garhyan P, Porksen N.

Diabetes Technol Ther. 2017 Aug;19(8):463-470. doi: 10.1089/dia.2016.0414.

14.

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.

Cameron FM, Ly TT, Buckingham BA, Maahs DM, Forlenza GP, Levy CJ, Lam D, Clinton P, Messer LH, Westfall E, Levister C, Xie YY, Baysal N, Howsmon D, Patek SD, Bequette BW.

Diabetes Technol Ther. 2017 Sep;19(9):527-532. doi: 10.1089/dia.2017.0078. Epub 2017 Aug 2.

PMID:
28767276
15.

How Low Can You Go? Reducing Rates of Hypoglycemia in the Non-critical Care Hospital Setting.

Kulasa K, Juang P.

Curr Diab Rep. 2017 Sep;17(9):74. doi: 10.1007/s11892-017-0902-3. Review.

PMID:
28755062
16.

Remote Monitoring and Consultation of Inpatient Populations with Diabetes.

Rushakoff RJ, Rushakoff JA, Kornberg Z, MacMaster HW, Shah AD.

Curr Diab Rep. 2017 Sep;17(9):70. doi: 10.1007/s11892-017-0896-x. Review.

PMID:
28726156
17.

COMPARISON OF EFFICACY AND SAFETY OF GLARGINE AND DETEMIR INSULIN IN THE MANAGEMENT OF INPATIENT HYPERGLYCEMIA AND DIABETES.

Galindo RJ, Davis GM, Fayfman M, Reyes-Umpierrez D, Alfa D, Peng L, Tamler R, Pasquel FJ, Umpierrez GE.

Endocr Pract. 2017 Sep;23(9):1059-1066. doi: 10.4158/EP171804.OR. Epub 2017 Jul 6.

PMID:
28683239
18.

Adherence to Guidelines for Inpatient Pharmacologic Management of Type 2 Diabetes and Glycemic Outcomes.

Alkhiari R, Alzayer H, Aljazeeri J, Vanniyasingam T, Punthakee Z.

Can J Diabetes. 2017 Jun 26. pii: S1499-2671(17)30170-3. doi: 10.1016/j.jcjd.2017.05.003. [Epub ahead of print]

PMID:
28662968
19.

Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review.

Timlin MR, Black AB, Delaney HM, Matos RI, Percival CS.

Pediatr Cardiol. 2017 Aug;38(6):1247-1250. doi: 10.1007/s00246-017-1652-3. Epub 2017 Jun 22. Review.

PMID:
28642988
20.

Predicting inpatient hypoglycaemia in hospitalized patients with diabetes: a retrospective analysis of 9584 admissions with diabetes.

Stuart K, Adderley NJ, Marshall T, Rayman G, Sitch A, Manley S, Ghosh S, Toulis KA, Nirantharakumar K.

Diabet Med. 2017 Oct;34(10):1385-1391. doi: 10.1111/dme.13409. Epub 2017 Jul 12.

PMID:
28632918

Supplemental Content

Loading ...
Support Center